Treatment Approaches to Chronic Lymphocytic Leukemia With High-Risk Molecular Features

The clinical course of chronic lymphocytic leukemia (CLL) is highly variable. Over the past decades, several cytogenetic, immunogenetic and molecular features have emerged that identify patients suffering from CLL with high-risk molecular features. These biomarkers can clearly aid prognostication, b...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Straten, Lina, Hengeveld, Paul J., Kater, Arnon P., Langerak, Anton W., Levin, Mark-David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695615/
https://www.ncbi.nlm.nih.gov/pubmed/34956898
http://dx.doi.org/10.3389/fonc.2021.780085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695615/
https://www.ncbi.nlm.nih.gov/pubmed/34956898
http://dx.doi.org/10.3389/fonc.2021.780085

Ejemplares similares